2009, Number 1-4
<< Back Next >>
Rev Neurol Neurocir Psiquiat 2009; 42 (1-4)
Prevalence of anxiety and depression in patients with HIV/AIDS. Comparative study with patients with other infections diseases
Romero TJM
Language: Spanish
References: 14
Page: 25-31
PDF size: 143.96 Kb.
ABSTRACT
Material and methods. Observational, transverse and
comparative study. The sample to study considers patient
that entered to the room of Infectology of Adults of the Military
Central Hospital, they were divided in two groups, a
group considered with HIV/AIDS and a group control
without HIV/AIDS with other infectious diseases. To these
patients they were applied scales of depression evaluation
and anxiety. The used statistical analysis was the descriptive
statistic and for the comparison of the groups the test of
Mann-Whitney.
Results. The prevalence among the group HIV/AIDS
and anxiety, according to the Scale of Anxiety of Hamilton
was of 90% of the group with HIV/AIDS (n = 36 of 40) and
87.5% of the group comparative control (n = 35 of 40) (p =
0.050).
The prevalence among the group with HIV/AIDS and
the depression, according to the Scale of Depression of
Hamilton was of the 90% of the patient one of the group
with HIV/AIDS and 82% in the group comparative control
(p = 0.002).
Conclusions. The patients with HIV/AIDS of the room of
Infectology of the Military Central Hospital sample a high
prevalence of anxiety and depression; however, the intensity
is most evident in the group with HIV/AIDS. This study
suggests the deliberate evaluation of anxiety and depression
in all the patients with confirmed recent diagnosis of
HIV/AIDS, future investigations will also be focused to
identify the factors of risk that predispose to the anxiety
and depression in our population.
REFERENCES
Greene WC. The molecular biology of human immunodeficiency virus type 1 infection. N Engl J Med 1991; 324: 308-17.
HIV/AIDS Surveillance Report. Atlanta, Centers for Disease Control and Prevention, 1997; 9(2).
Rodin G, Voshart K. Depression in the medically ill: an overview. Am J Psychiatry 1986; 143: 696-705.
Katon W, Shulberg H. Epidemiology of depression in primary care. Gen Hosp Psychiatry 1992; 14: 237-47.
Fukunishi I, Matsumoto T, Neigishi M, Hayashi M, Hosaka T, Moriya H. Somatic complaints associated with depressive symptoms in HIV-positive patients. Psychother Psychosom 1997; 66: 248-51.
Dew MA, Becker JT, Sanchez J, Caldararo R, López OL, Wess J, Dorst SK, Banks G. Prevalence and predictors of depressive, anxiety, and substance use disorder in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med 1997; 27: 395-409.
Rabkin JG, Ferrando SJ, Jacobsberg LB, Fishman B. Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Compr Psychiatry 1997; 38: 146-54.
Chuang HT, Jason GW, Pajurkova EM, Gill MJ. Psychiatric morbidity in patients with HIV infection. Can J Psychiatry 1992; 37: 109-15.
Davis RF, Metzger DS, Meyers K, McLellan AT, Mulvaney FD, Navaline HA, Woody GE. Long-term changes in psychological symptomatology associated with HIV status among male injecting drug users. AIDS 1995; 15: 73-9.
Cassem ND. Manual de psiquiatría en hospitales generales; cuarta edición. España: Harcourt Brace; 1998, p. 37-220.
Roberts JE, Ciesla JA, Direnfeld DM, Hewitt R. Vulnerability to psychological distress among HIV-positive individuals: the roles of acute stressful life events and neuroticism. Can J Psychiatry 2001; 30: 241-57.
Perry SW, Jacobsberg L, Fishman B, Weiler P, Gold J, Frances A. Psychological responses to serological testing for HIV. AIDS 1990; 4: 145-52.
Cleary PD, Singer E, Rogers TF, Avorn J, Van Devanter N, Soumerai S, Perry S, Pindyck J. Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors. Am J Public Heath 1988; 78: 953-7.
Jacobsen PB, Perry SW, Hirsch D. Behavioral and psychological responses to HIV antibody testing. J Consult Clin Psychol 1990; 58: 31-7.